Cargando…
Systemic generalised lymphangiomatosis: unknown aetiology and a challenge to treat
We describe a case of a woman diagnosed at the age of 35 years with a generalised mediastinal and abdominal lymphangiomatosis associated with a protein losing enteropathy, who successfully improved when treatment with sirolimus was initiated.
Autores principales: | Van Meerhaeghe, Tess, Vandenbroucke, Frederik, Velkeniers, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813405/ https://www.ncbi.nlm.nih.gov/pubmed/33462010 http://dx.doi.org/10.1136/bcr-2020-237331 |
Ejemplares similares
-
Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis)
por: Luisi, Francesca, et al.
Publicado: (2016) -
Diffuse pulmonary lymphangiomatosis treated with bevacizumab
por: Onyeforo, Ernest, et al.
Publicado: (2018) -
Perirenal Lymphangiomatosis
por: Jeon, Tae Gyeong, et al.
Publicado: (2014) -
Kaposiform lymphangiomatosis effectively treated with MEK inhibition
por: Foster, Jessica B, et al.
Publicado: (2020) -
Lymphangiomatosis With Hemihypertrophy
por: Waler, James A., et al.
Publicado: (2016)